Article: [Evidence mapping of Chinese patent medicines in treatment of premature ventricular contractions].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
2024 Volume 49, Issue 5, Page(s) 1397–1405
Abstract: This study employed evidence mapping to systematically sort out the clinical studies about the treatment of premature ventricular contractions with Chinese patent medicines and to reveal the distribution of evidence in this field. The articles about the ... ...
| Abstract | This study employed evidence mapping to systematically sort out the clinical studies about the treatment of premature ventricular contractions with Chinese patent medicines and to reveal the distribution of evidence in this field. The articles about the treatment of premature ventricular contractions with Chinese patent medicines were searched against PubMed, Cochrane Library, Web of Science, CNKI, Wanfang, and VIP with the time interval from January 2016 to December 2022. Evidence was analyzed and presented by charts and graphs combined with text. According to the inclusion and exclusion criteria, 164 papers were included, including 147 interventional studies, 4 observational studies, and 13 systematic reviews. A total of 27 Chinese patent medicines were involved, in which Shensong Yangxin Capsules and Wenxin Granules had high frequency. There were off-label uses in clinical practice. In recent years, the number of articles published in this field showed a decreasing trend. Eight types of outcome indicators were used in interventional studies. Ambulatory electrocardiography, clinical response rate, safety, and echocardiography had high frequency, while the rate of β-blocker decompensation, major cardiovascular events, and pharmaceutical economic indicators were rarely reported. The evaluation was one-sided. The low quality of the included articles reduced the reliability of the findings. In the future, the clinical use of medicines should be standardized, and the quality of clinical studies should be improved. Comprehensive clinical evaluation should be carried out to provide a sound scientific basis for the treatment of premature ventricular contractions with Chinese patent medicines. |
|---|---|
| MeSH term(s) | Humans ; Ventricular Premature Complexes/drug therapy ; Nonprescription Drugs/therapeutic use ; Reproducibility of Results ; Drugs, Chinese Herbal/therapeutic use ; Medicine, East Asian Traditional ; Capsules |
| Chemical Substances | Nonprescription Drugs ; Drugs, Chinese Herbal ; Capsules |
| Language | Chinese |
| Publishing date | 2024-03-11 |
| Publishing country | China |
| Document type | English Abstract ; Journal Article |
| ZDB-ID | 1004649-5 |
| ISSN | 1001-5302 ; 0254-0029 |
| ISSN | 1001-5302 ; 0254-0029 |
| DOI | 10.19540/j.cnki.cjcmm.20231125.501 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 3056: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.